Palo Alto-based ConsultingMD, which is developing an online service to connect patients with second opinions from medical experts, has raised $10M in a funding round. The round came from Venrock. The company said it will use the funds to fu...

Redwood City-based Proteus Digital Health has raised $62.5M in a Series F financing, the firm said Wednesday. The funding came from Oracle, Otsuka, Novartis, Sino Portfolio and the company's other investors. Proteus Health is developing "d...

Mountain View-based Conceptus, a developer of non-surgical, permanent birth control devices, has been acquired by Bayer Healthcare, the two announced this morning. According to the two, Bayer HealthCare has signed a merger agreement with CO...

Mountain View-based drchrono, which develops iPad applications for viewing electronic health records (EHR), said Thursday that it has received an investment from cloud storage provider Box. Financial details of the investment were not discl...

San Mateo-based Cervel Neurotech, a developer of medical devices which use magnetic coils to treat psychiatric and neurologic illnesses, said today that it has raised $14.1M in a new funding round. The funding came from D. E. Shaw Ventures ...

San Francisco-based iRhythm Technologies, a developer of patch-based, cardiac monitoring products, said today that it has raised $16M in a Series D funding round. The funding was led by Norwest Venture Partners, and also included New Leaf V...

Burlingame-based biopharmaceuticals developer Cleave Biosciences has raised another $10M in its Series A funding round, the firm announced today. According to Cleave, the new funding came from New Enterprise Associates. The funding brings i...

San Ramon-based SteadyMed Therapeutics, a developer of biopharmaceuticals to treat Pulmonary Arterial Hypertension (PAH), has raised $3M in a term loan from Square 1 Bank. Square 1 Bank said the loan will go towards working capital, to help...

Brisbane, California-based SARcode Bioscience said Monday that it is in an acquisition deal with Shire US Holdings, the global specialty biopharmaceuticals firm. SARcode said that Shire will pay $160M plus additional, undisclosed payments b...

San Francisco- and Boston-based Third Rock Ventures, which invests in healthcare companies, said Monday that it has raised $516M in its third fund, Third Rock Fund III. The firm said the fund was oversubscribed. The new fund brings its tota...

Menlo Park-based CardioKinetix said Thursday that it has raised $48M in a Series E financing, for its catheter-based heart failure therapies. The new funding round came from Panorama Capital, along with prior investors U.S. Venture Partners...

Hayward-based Solta Medical, the developer of medical aesthetics products, said this week that it has completed its acquisition of Sound Surgical Technologies. The deal was worth $25.5M in Solta common stock, $5.0M in cash, plus up to $9.5M...

Menlo Park-based Intersect ENT, which develops sinus implants used to treat ear, nose and throat patients, said today that it has raised $30M in a Series D round of funding. The round was led by Norwest Venture Partners, and also included ...

Redwood City-based Gynesonics, a developer of minimally invasive products for treating uterine fibroids in women, said today that it has raised $21M in a Series F funding round. The round was led by HBM Partners, and also included Correlati...

San Ramon-based Odyssey Thera, a developer of technology which measures disease pathways in human cells, said Thursday that it has raised $2.8M in funding. The funding came from HBM Partners, Burrill & Company, and Lonza. According to Odyss...

Hayward-based Solta Medical, which develops medical aesthetics products, has acquired SOund Surgical Technologies, in a deal worth $25.5M in stock, $5.0M in cash, plus up to $9.5M in earnout. Sound Surgical Technologies develops surgical an...

Mountain View-based MAP Pharmaceuticals, a publicly held developer of biopharmaceuticals aimed at treating migraines in adults, has been acquired by Allergan. The two said that Allergan will pay $25.00 per share for MAP, or approximately $9...

Palo Alto-based Syapse, which operates an online repository of human genome and clinical data, said this morning that it has raised a round of funding from The Social+Capital Partnership. Size of the funding round was not disclosed. Syapse ...

San Mateo-based Epocrates, the publicly held developer of mobile medical applications, has been acquired by Athenahealth, the two said this week. Athenahealth said it would pay $11.75 per share in cash, or approximately $293M, for Epocrates...

San Francisco-based Soltice Biologics said Friday that it has raised $18M in a Series A funding round. The firm, which is developing technology that enables the delivery of RNA-based therapeutics across membranes, said the funding was led b...

San Francisco-based Labrys Biologics, a biopharmaceuticals firm focused on treatments for chronic migraine, said this morning that it has raised $31M in a Series A financing round. The round came from venBio, Canaan Partners, InterWest Part...

Livermore-based Halt Medical has raised $15M in a funding round, which will go toward commercialization of its medical devices for treating uterine fibroids, the firm said this morning. Halt Medical said its system was recently cleared by t...

Redwood City-based Ascend Clinical, a provider of end-stage renal disease laboratory testing, has acquired the diagnostics laboratory business of PathCentral. Financial terms of the buy were not announced. PathCentral provides diagnostics t...

Palo Alto-based LUMO BodyTech, a developer of sensors, devices, and software which monitors a user's posture to help improve back health and reduce back pain, has raised $5M in a Series A funding round. The round was led by Madrona Venture ...

San Mateo-based Allakos said today that it has raised $32M in a Series A financing round, which will go towards its antibody therapeutics for treating allergic and inflammatory diseases. The funding was led by Novo Ventures, and also includ...

Mountain View-based 23andMe, the personalized genetics company led by Anne Wojcicki, said yesterday that it has received more than $50M in a new financing round. The round came from new investor Yuri Milner, and also included Sergey Brin, N...

Larkspur-based BioCision, which develops tools for the life sciences research and clinical research market, said today that it has raised $2.5M in a growth financing round. The round came from BroadOak Capital Partners, along with Research ...

Mountain View-based Edison Pharmaceuticals, a biopharmaceuticals firm developing treatments for mitochondrial diseases, has raised $20M in a Series F funding. The round was led by Mitsui & Co. Edison said the funding will go to advance clin...

Pleasanton-based TriReme Medical, a developer of medical devices for treating peripheral arterial disease, said today that it has raised $18M in a funding round. The round was led by Luminor Capital of Singapore, and also included other, un...

Hayward-based Intarcia Therapeutics announced Thursday that it has raised $210M in a combination of equity and debt. The developer of diabetes treatment said it raised $160M in a preferred stock private placement, and $50M in private debt. ...

Walnut Creek-based Beyond Lucid, a firm which helps provide tracking of documentation for the emergency response industry, said today that it has raised a "six figure" convertible note from Dalmore Investments. Exact amount of the funding w...

Remedy Informatics, a developer of clinical registries, medical research software, and research informatics for the life sciences industry, has raised $6M. The firm, which has offices in Menlo Park, said the funding came from the Merck Glob...

Redwood City-based Pearl Therapeutics said today that it has raised $65M in a Series D funding round. The round came from its existing investors, which include 5AM Ventures, Clarus Ventures, New Leaf Venture Partners, and Vatera Healthcare ...

San Francisco-based Drip Drop, a developer of medically forumlated, oral rehydration solutions used to treat dehydration and other issues, said today that it has raised a round of equity funding. Size of the funding round was not disclosed....

Hayward-based Advanced Cell Diagnostics said this morning that it has raised $12M in a Series B funding round. The firm, which is developing automated tools for detecting and quantifying RNA biomarkers, said the round was led by New Leaf Ve...

San Francisco-based Principia Biopharma, a pharmaceuticals firm developing small molecule drugs aimed at treating inflammatory, autoimmune diseases, and cancer, has raised $12.5M in a second tranche of funding. The funding came from New Lea...

Menlo Park-based venture capital investor Longitude Capital said today that it has raised $385M for its second, life sciences fund, Longitude Venture Partners II. The firm said it had targeted the fund at $325M. Longitude invests in growth ...

South San Francisco-based KaloBios Pharmaceuticals has filed for an IPO, saying that it is looking to raised $60M on the NASDAQ Global Market as KBIO. The firm's IPO is being underwritten by Leerink Swann, William Blair, and Needham & Compa...

Alameda-based Singulex, a developer of diagnostics tests for diagnosing and monitoring chronic diseases, has filed for an IPO, saying that it is looking to raised up to $86.25M on the New York Stock Exchange. The firm, whose initial tests a...

San Francisco-based Myokardia, a newly formed developer of small molecule therapeutics, said today that it is targeting genetic heart disease with $38M in funding. The Series A funding came from Third Rock Ventures. MyoKardia is developing ...

Redwood City-based Station X, a developer of software used for analyzing and visualizing genome data, has raised $5M in a second round of funding, the firm said today. The funding was led by Runa Capital, and also included Genomic Health. T...

Mountain View-based Complete Genomics has found a buyer for the firm, Chinese company BGI-Shenzhen. the two said this morning. The two said that they have entered into a definitive merger agreement where BGI Biotech will pay $3.15 per share...

San Mateo-based Doximity, developer of a mobile app driven, social networking platform for doctors, has raised $17M in funding. The funding was led by Morgenthaler Ventures. The new funding brings its total raised to $27.8M. Doximity is led...

San Francisco-based MyHealthTeams, which develops online, social networks specifically geared towards patients with individual, chronic health conditions, said today that it has raised $1.75M in a seed funding round. The round was led by Ad...

San Francisco-based CytomX Therapeutics, a developer of antibody therapeutics, said Tuesday that it has raised $41M in an expanded, Series B financing round. The round was led by Canaan Partners, and also included Third Rock Ventures and th...

San Francisco-based personalized DNA and genetics testing firm Navigenics has been acquired by Life Technologies, a developer of life sciences equipment. Financial terms of the acquisition were not disclosed. Navigenics was venture backed b...

Redwood City-based Avinger, a developer of medical devices used for treating peripheral artery disease (PAD), said yesterday that it has raised $33M in a Series D funding round. The firm said its existing major investors participated in the...

Hayward-based GenturaDx, a developer of molecular diagnostics products used for PCR analysis, has been acquired by Luminex Corporation. The deal was worth $50M in cash, plus unspecified earnout. GenturaDx was venture backed by Bay City Capi...

Santa Clara-based Benvenue Medical, a developer of minimally invasive products used for spine repair, said yesterday that it has raised $25M in a Series D funding round. The round came from existing investors DeNovo Ventures, Domain Associa...

San Francisco-based Practice Fusion, a developer of web-based, electronic medical records (EMR) software, announced this morning that it has raised $34M in a financing round. The round was led by Artis Ventures, and also included Felicis Ve...

San Francisco-based Gemmus Pharma, a developer of treatments for influenza, said today that it has raised a Series A funding. Size of the round was not disclosed. The round was led by Life Science Angels, and also included BlueTree Allied A...

Sunnyvale-based Aptus Endosystems, which is developing medical devices used for endovascular aneurysm repair (EVAR), said Wednesday that it has raised $25M in a equity funding round. The round was led by Synergy Life Science Partners, and ...

Redwood City-based EndoGastric Solutions, a developer of medical devices for treament of Gastroesophageal Reflux Disease (GERD), said Thursday that it has raised $13M in additional funding, a Series F extension for the company. The round c...

San Francisco-based Global Blood Therapeutics said this week that it has raised $40.7M in a Series A financing, for its efforts to develop oral, small molecule drugs for treating conditions such as sickle cell disease. The funding came from...

San Francisco-based Invuity, which develops surgical illumination and visualization technology, announced this morning that it has raised $25M in a Series D funding round. The funding was led by Valence Advantage Life Sciences Fund II, and ...

San Jose-based C8 Medisensors, a developer of medical devices which use light to measure blood glucose levels in people with diabetes, has raised $19M in a preferred stock financing, the firm said this week. Source of the funding was not an...

San Francisco-based CellScope, a developer of software that uses cellphone cameras to help diagnose pediatric ear infections, has raised $1M in a funding round, the firm said Monday. The seed funding came from Khosla Ventures. CellScope's s...

Burlingame-based Igenica, a developer of biopharmaceuticals focused on the cancer market, has raised $33M in a Series C funding round. The round was led by Third Rock Ventures, and also included The Column Group, Orbimed Advisors and 5AM Ve...

San Francisco-based AliveCor, which develops mobile electrocardiogram (ECG) devices, said today that it has raised $10.5M in a Series B funding round. The round was led by Burrill & Company and Khosla Ventures, and also included Qualcomm Ve...

San Francisco-based Ringadoc, a provider of service which allows users to call up doctors for medical device using their phone or computer, has raised $750,000 in a seed funding round. The firm said the funding came from FF Angel, Ryan Howa...

Menlo Park-based Auxogyn, a developer of health testing technology to test the viability of embryos during in vitro fertilization (IVF), has raised $18M in a Series B funding round, the company said today. The round was led by SR One, and a...

Mountain View-based Complete Genomics, the onetime high flying provider of whole human genome sequencing services, said today that it has cuts its staff, and has hired an investment banking firm to assist in "strategic alternatives." The fi...

Redwod City-based SentreHEART, the develope rof a medical device used for suturing soft tissue, has raised $26M in a Series C financing round, the firm announced. The round was led by Vivo Ventures, and also included US Venture Partners and...

Mountain View-based PneumRx, a developer of medical devices for minimally invasive treatment of lung disease, said it has acquired the patents and domain names from Broncus Technologies. Financial terms of the acquisition were not disclosed...

San Francisco-based Nurix, a stealth mode startup which looks to be headed by Timothy Kutzkey, a venture capitalist at The Column Group, has raised $3.1M in a funding, according to a regulatory filing by the firm. Details on what the compan...

Redwood City-based OncoMed Pharmaceuticals filed for an IPO Friday, saying that it is looking to raised up to $115M on the NASDAQ Global Market as OMED. The firm's IPO is being underwritten by Jefferies, Leerink Swann, Piper Jaffray, and...

Sacramento-based SynGen, which is developing stem cell harvesting systems for the regenerative medicine market, has raised $5M in a Series A funding. The round came from Bay City Capital. According to the firms, Bay City Capital will add tw...

South San Francisco-based Hyperion Therapeutics has filed for an IPO, saying that it is looking to raise up to $57.5M in an IPO on the NASDAQ Global Market. The firm has applied to list as HPTX. Hyperion is a developer of biopharmaceuticals...

South San Francisco-based KAI Pharmaceuticals, a biopharmaceuticals firm development treatment of secondary hyperparathroidism in patients with chronic kidney disease on dialysis, has been acquired by Amgen, the firms said today. Amgen said...

Redwood Shores-based Oracle said this morning that it has acquired ClearTrial, a developer of cloud-based, clinical trial tracking software. Financial terms of the by were not disclosed. Oracle said that ClearTrial's software helps make the...

Redwood City-based Relievant MedSystems, a developer of medical devices being targeted at treating low back pain, said today that it has raised $30M in a Series D funding round. The round was led by New Enterprise Associates, and also inclu...

Mountain View-based TheraVida, a developer of drugs to treat overactive bladder and urinary incontinence, has now raised $8.9M in its latest funding round, according to a recent regulatory filing from the firm. Details on the funding have n...

Redwood City-based Myoscience, a developer of medical devices which use cold to treat wrinkles, pain, and certain dermatologic conditions, said today that it has raised $33M in a Series D funding round. The round came from Accuitive Medica...

Livermore-based Halt Medical, a medical devices firm which is developing equipment to treat uterine fibroids, has raised $20M in debt and equity funding. The funding came from American capital, Ltd., along with other affiliates. Terms of th...

Palo Alto-based Varian Medical Systems, which manufactures medical devices and software for the radiotherapy, radiosurgery, and brachytherapy market, announced today that it has acquired InfiMed, a developer of workstations for processing d...

Menlo Park-based Health Fidelity said last week that it has raised a Series A funding round, to apply to its efforts to use natural language processing to mine for clinical healthcare data. The firm did not disclose the size of the funding....

Livermore-based HALT Medical, a developer of medical devices for treating uterine fibroids, announced today that it has raised $20M in the first part of an ongoing, $50M funding round.The firm said the debt and equity funding came from Amer...

Menlo Park-based Velomedix, which is developing medical devices which use hypothermia to treat cardiac arrest and stroke patient, has raised $10.2M in a Series B funding. Source of the funding was not announced by the company. As part of th...

Menlo Park-based Auxogyn, which is developing a system to improve invitro fertilization, said today that it has closed out its Series A round at $20M. According to the firm, the final tranche of its Series A included Kleiner Perkins Caufiel...

Mountain View-based drchrono, a developer of mobile healthcare software, including electronic health records, prescription, medical billing, and patient management tools, said last week that it has raised $2.8M in a funding round. The round...

Palo Alto-based Glooko, a developer of a mobile application and cables to pull and log information from glucose meters for the diabetic, has raised $3.5M in a Series A funding. The round came from The Social+Capital Partnership, along with ...

Saratoga-based VisionCare Opthalmic Technologies has closed an expansion of the firm's Series E financing, the company said this week. The funding was led by Agate Medical Investments. Size of the round was not disclosed. As part of the fun...

San Francisco-based Practice Fusion, which develops electronic medical records, said this morning that it has raised $2M more in funding for the company. The funding came from angels Jed Stremel (Facebook), Ali Partovi (LinkExchange), and H...

Redwood City-based Avinger, a maker of multi-functional catheters used for patients with Peripheral Artery Disease (PAD), said today that it has closed on $22.5M in a Series C funding. The round came from its existing investors, along with ...

San Jose-based Aria Diagnostics, a developer of molecular diagnostic test for prenatal and maternal health, reported this morning that it has raised $52.7M in a Series C funding round. The round came from Meritech Capital Partners, an un-na...

Menlo Park-based 3-V Biosciences, which is developing treatments for Hepatitus C (HCV), said this week that it has closed a preferred round of funding, worht a minimum of $20M. The round came from Kleiner Perkins Caufield & Byers and New En...

Emeryville-based Bionovo, a publicly held developer of pharmaceuticals for treating both menopause and cancer, said yesterday that it has raised $5M in a private investment. The funding came from Socius CG II, Ltd, a Bermuda-based investmen...

San Carlos-based PharmacoFore, a biopharmaceuticals firm working on compounds to treat diseases of the central and peripheral nervous systems, said Tuesday that it has raised $10M in an equity funding round. The round came from the Founders...

Pleasanton-based IntegenX, which is developing rapid human DNA identification technology, said this morning that it has raised $40M in a Series C funding. The funding was led by Essex Woodlands, and also included Domain Associates, QuestMar...

Mountain View-based Hansen Medical, a publicly traded developer of robotic catheters, said Friday that it has raised $30M in a debt facility. The funding came from Oxford Finance and Silicon Valley Bank. Hansen Medical said the financing wi...

Palo Alto-based HealthTap, a new startup which allows users to ask any health question online, and get an answer from a real doctor for free, announced today that it has raised $11.5M in a Series A funding. The funding was led by Mayfield F...

Santa Clara-based Affymetrix said Wednesday that it is acquiring eBioScience, a privately held developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The deal was worth $330M in cash. Priv...

Petaluma-based Tegal, a developer of a wide range of semiconductor and MEMs devices and technology, said this morning that it has invested $300,000 in NanoVibronix, an Israeli ultrasound technology developer. NanoVibronix is developing low-...

Sunnyvale-based BARRX Medical, a developer of minimally invasive medical devices, said yesterday that it has agreed to be acquired by Coviden. The deal is worth approximately $325M, plus future earn out. BARRX develops endoscopy devices use...

South San Francisco-based Portola Pharmaceuticals announced Monday that it has raised $89M in a preferred stock financing round. The firm, which is developing therapeutics aimed at cardiovascular and autoimmune/inflammatory disease, said th...

San Carlos-based Live Leaf Biosciences, a startup developing plant-based treatments for diarrheal disease, antibiotic alternatives, and wound care, has raised $2.6M in a funding round, according to a regulatory filing from the firm. Detail...

Sunnyvale-based Pivot Medical, a developer of minimally invasive technologies for hip arthroscopy, said Tuesday that it has raised $32M in a series C funding round. The round was led by Adams Street Partners, and also included Delphi Ventu...

Palo Alto-based Comprehend, a developer of clinical data visualization, analytics, and reporting software for the clinical research industry, said today that it has raised $1.2M in a seed funding round. The round came from Y Combinator, S...

San Jose-based DFINE, a developer of minimally invasive radiofrequency therapies for treating vertebral fractures, announced today that it has raised $25M in a funding round. The funding came from OrbiMed Advisors, Prospect Venture Partners...

Hayward-based Solta Medical, a developer of medical aesthetics products, said this week that it has expanded a credit line from Silicon Valley Bank. The firm said it has expanded the line from $18M to $28M, with the new $10m under a secured...

Redwood City-based Ziosoft, a developer of software used for 4D and 5d medical imaging on supercomputers, has been acquired by Nantworks, a technology incubation and development firm run by Patrick Soon-Shiong, a billionaire investor in Los...

Eric Schmidt, the Executive Chairman and former CEO of Google, has backed an Indian developer of pharmaceuticals security technology. According to PharmaSecure, a developer of anti-counterfeiting technology for pharmaceuticals, it raised $3...

San Francisco-based goBalto, a developer of web-based, clinical research software, said today that it has raised an undisclosed amount of Series A financing. The Series A came from Aberdare Ventures and the West Health Investment Fund. A re...

Pleasanton-based ZELTIQ Aesthetics, the developer of an aesthetic medical product used for selectively reducing fat bulges, has set its initial IPO range, according to an updated S-1 from the company today. ZELTIQ said it estimates its IPO ...

SV Life Sciences, the venture capital investment firm with offices in Boston, San Francisco, and London, said Wednesday afternoon that it ha named Dr. Heiner Dreismann as a new Ventuer Partners. Dr. Dreismann has previously served at Roche ...

San Francisco-based SpineGuard, a developer of a medical device used by surgeons for minimally invasive spine surgery, said Tuesday that it has raised $6.2M in a funding round. The funding came from Credit Agricole Private Equity, Innoven P...

San Jose-based SI-BONE, which develops a minimally invasive surgical devices for treating the sacroiliac joint, said this morning that it has raised $16.0M in a financing round. The firm said the funds will go towards expansion of its clini...

Redwood City-based CardioKinetix, the developer of transcatheter implants used to treat patients with heart failure, has raised $44M, the firm said, in a Series E financing round. The funding came via two tranches, and was led by SV Life Sc...

Palo Alto-based Varian Medical Systems and Seattle-based Calypso Medical Technologies said Monday that Varian is acquiring Calypso for $10M, plus potential earnout. Calpyso is a developer of tumor tracking and motion management systems for ...

San Francisco-based Practice Fusion, a developer of electronic health records software, said today that it has raised $6M in a new funding round. The round came from Western Technology Investment, Scott Banister, Founders Fund, Morgenthaler...

Mountain View-based Edison Pharmaceuticals, a developer of treatments for inherited mitochondrial diseases and other rare and neglected diseases, said today that it has raised a Series E preferred financing round. Financial details of the f...

South San Francisco-based Crescendo Bioscience, which develops molecular diagnostic tests for rheumatoid arthritis and other inflammatory diseases, said today that it has raised $31M in a Series C equity funding, plus a $25M strategic inves...

Fremont-based Ardelyx, a biopharmaceuticals firm developing treatments for irritable bowel syndrome, kidney disease, and diabetes, said Tuesday that it has raised $30M in a Series B funding round. The round included New Enterprise Associate...

Kleiner Perkins Caufield & Byers is the lead investor in a developer of real time, location systems for the healthcare market. In an unusual move for Kleiner, the firm was a new investor in a Series F funding round for Awarepoint, who syste...

Mountain View-based Restoration Robotics, a medical device firm developing technology for harvesting hair follicles during hair restoration procedures, said last week that it has raised $41M in a Series C financing round. The round was led ...

San Francisco-based Second Genome, a firm developing microbial-based, personalized medicine products for the gastrointestinal disease area, said yesterday that it has raised $5M in a funding round. The round was co-led by Advanced Technolog...

San Carlos-based Verinata Health, a firm developing diagnostic test for monitoring maternal and fetal health, announced today that it has raised $48.5M in a Series C funding round. The firm said the round was led by Mohr Davidow Ventures, S...

Sunnyvale-based Intuity Medical announced this morning that it has raised $76M in funding, in a second close of a previously announced Series D funding. The new funding added Accuitive Medical Ventures, which joins the firm's prior investor...

Brisbane-based SARcode Bioscience, a firm developing treatments for inflammatory disease, said this morning it has raised $44M in a Series B financing round. The round was led by Sofinnova Ventures, and also included Rho Ventures, Alta Part...

Menlo Park-based Transcend Medical, which is developing opthalmic devices for treating glaucoma, has raised $51M in its Series B round, the firm said this week. The new funding came as part of a second tranche in the Series B round. The fir...

Sunnyvale-based Sorbent Therapeutics, a biopharmaceuticals firm targeting the cardiovascular and renal disease area, has raised $36M in a Series B financing round. The firm said the funding was led by Novartis Venture Funds, and includes ex...

Burlingame-based Redwood Bioscience, a firm focused on antibody-drug conjugates and peptide therapeutics, said today that it has secured new funding from Takeda Venturse. Amount of the funding was not disclosed. The firm said the funding wi...

Novato-based BioMarin Pharmaceutical said Thursday that it is in a deal to buy a 133,000 square foot, bulk biologics manufacturing plant from Pfizer. the plant is located in Shanbally, Cork, Ireland. BioMarin said it paid $48.5M for the pla...

Novato-based Ultragenx Pharmaceuticals said today that it has raised $45M in a Series A funding round. The round was led by TPG Biotech and Fidelity Biosciences, and also included HealthCap and Pappas Ventures. According to the firm, the fu...

Mountain View-based PolyRemedy, a developer of chronic wound care treatment systems, said today that it has raised $20M in a Series C funding round. The round was led by Delphi Ventures, and also included prior investors Advanced Technology...

Palo Alto-based ADVANCE MEdical, which is helping to commercialize pharmaceuticals and medical device technologies in Brazil and other Latin American countries, said Wednesday that it has raised $6M in a Series A financing round. The round ...

Alameda-based CoolSystems, the maker of an cold therapy system aimed at the athletics market, has raised $4.0M in what looks to be a convertible debt round still in progress. Details on the funding have not been announced by the company. Ac...

Santa Clara-based Cell Biosciences, a developer of scientific equipment for protein analysis, said Thursday that it has acquired Brightwell Technologies, in a deal worth $9M in cash. Brightwell was based in Ottawa, Ontario, and develops mic...

Sunnyvale-based U-Systems, a developer of ultrasound technology for breast imaging, said today that it has raised another $6.5M in funding. The firm said the new funding came from existing investors, which include iD SoftCapital Group, Lumi...

Santa Clara-based Crown Biosciences, a provider of clinical testing services for the oncology pharmaceuticals development market, said this mornign that it has raised $28.8M in a Series C financing round. The roun was led by OrbiMed Advisor...

Redwood City-based OncoHealth, a developer of tests for cervical cancer and other cancers caused by human papillomavirus (HPV) viruses, has raised $1.6M in a Series A investment, the firm said today. The funding included Sand Hill Angels, B...

Mountain View-based Xlumena, a developer of medical devices for the endoscopy market, said last night that it has raised $7M in a Series B financing round. The round was led by Aperture Venture Partners, and also included Western Technology...

Fremont-based AngioScore, a developer of angioplasty catheters, said Wednesday that it has raised $12M in new private equity financing. The financing game from Saints Capital, and also included Psilos Group Managers, Telegraph Hill Partners...

Santa Clara-based Benvenue Medical, which is developing minimally invasive products for spine repair, has raised $35.5M in a Series C funding roudn, the firm said today. The funding was co-led by Domain Associates and Technology Partners, a...

Palo Alto-based Nfocus Neuromedical, a firm developing treatments for brain aneurysms, has raised $7.5M as part of an ongonig, $12.5M funding round, according to a regulatory filing by the firm this week. No detail on the new funding was di...

San Francisco-based GoBalto, a startup developing web-based software for managing clinical trials, has raised $2.87M out of a $3.5M fundraising round. The funding was revealed in a recent regulatory filing. GoBalto is headed by Jae Chung. T...

Newark, California-based Oraya Therapeutics, a developer of noninvasive, robotically controlled systems for treating eye disorders, has raised another $15.875M in funding, according to a regulatory filing by the firm. The round comes on $5....

San Francisco-based Practice Fusion said earlier today that it has raised $23M in a Series B funding round. The provider of electronic health and medical records software said the funding was led by Founders Fund, and also included Artis Ca...

San Mateo-based Doximity, a health technology firm developing a service which allows doctors to use their iPhone, iPad, or Android device to connect with other physicians on patient treatment and referrals, has raised $10.8M in a Series A f...

Sunnyvale-based Tibion Corp., a developer of bionic legs for stroke victims, said yesterday that it has raised $10.175M in a new funding round. The funding was led by Three Arch Partners and Hambrecht & Quist Capital Management. As part of ...

Berkeley-based Plexxikon, a developer of drugs for the treatment of melanoma cancer with the oncogenic BRAF mutation, has been acquired by Daiichi Sankyo, in a deal worth up to $935M. The firms said that Japanese pharmaceutical firm Daiichi...

Sunnyvale-based Intuity Medical, a developer of technologies for diabetes management, said today that it has secured a $20M credit facility from Silicon Valley Bank and Oxford Finance. The firm said the debt funding will go towards completi...

Foster City-based Gilead Sciences said today that it is acquiring Calistoga Pharmaceuticals, a Seattle developer of inflammatory, autoimmune, and cancer drugs. Gilead will pay $375M plus up to $225M in earnout for Calistoga. Calistoga was v...

Santa Rosa-based Sonoma Orthopedic Products, a developer of medical devices for treating fractures, said Monday that it has raised $22M in a Series D funding round. The round was led by Ascension Health Ventures, and also included Split Roc...

Pleasanton-based IntegenX, a provider of equipment used for preparing DNA and RNA samples for genetic analysis, said last week that it has raised $15.6M in a round of financing, and acquired GenVault Corporation. The funding round was led b...

San Francisco-based Massive Health, a stealth mode health care firm looking to apply crowdsourcing, game mechanics, and social networking to the healthcare field, has raised $2.25M in a seed funding round. The firm said the funding came fro...

San Mateo-based Epocrates surged in its IPO debut Wednesday, up to $21.42 after debuting on the NASDAQ as EPOC Wednesday morning at $16.00 per share. The firm sold 5,360,000 shares of its common stock. The IPO was underwritten by J.P. Morga...

South San Francisco-based Fluidigm has set the pricing range on its IPO, saying today in a filing with the SEC that it expects to offer 5,172,414 shares of its common stock at between $13.50 and $15.50 per share. Fluidigm is planning to lis...

Saratoga-based VisionCare Opthalmic Technologies, which develops visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), said this morning that it has raised another $31M in a ...

Mountain View-based PneumRx, a developer of medical devices for treating lung disease, said today that it has raised $33M in working capital commitments. According to the firm, the new funding was led by Forbion Capital Partners and Endeavo...

San Francisco-based Pipeline Healthcare, a provider of remote order entry and other pharmacy services delivered via phone to North American hospitals and retail pharmacies, said Friday that it had raised $2.5M in a funding round. The fundin...

Pleasanton-based QuantaLife, a developer of PCR equipment for the genetic sequencing market, said Friday that it has raised $17.2M in a Series B financing round. The round came from Paladin Capital Group, Merieux Developpement, and Vital Fi...

San Francisco-based Sequenta, a developer of a molecular diagnostics platform focused on immune system profiling, said today that it has raised $13M in a Series B funding round. The round came from Index Ventures, Mohr Davidow Ventures, and...

San Ramon-based Estech, a developer of a minimally invasive cardiac ablation surgical platform, said today that it has raised $8.5M in a funding round. The funding came from Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and...

Los Gatos-based Sadra Medical, a developer of a fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis, has been acquired by Boston Scientific, the firms said Friday afternoon. Ac...

San Francisco-based Sutro Biopharma, a developer of protein therapeutics technology, said today that it has raised $36.5M in a Series C funding round. The round was led by Skyline Ventures, and also included Lilly ventures, Amgen Ventures, ...

Redwood City-based AcelRX Pharmaceuticals has filed for an IPO, saying in a filing with the SEC late Friday that it is looking to raise up to $86.25M on the NASDAQ Global Market. The firm said it is looking to list as ACRX. The IPO is being...

Mountain View-based Complete Genomics, a provider of gene sequencing services, has priced its IPO, saying in a filing Wednesday afternoon that it expects its initial public offering price to be $9.00 per share, and will offer up 6 million s...

Pleasanton-based Thoratec said today that it has sold its International Technidyne Corporation (ITC) division to private equity firm Warburg Pincus. The deal was worth $55M in cash. Thoratec said the sale will allow it to focus on its exist...

Redwood City-based Gene Security Network, a provider of molecular diagnostics products for single cell testing for chromosome abnormalities and genetic diseases, said today that it has raised $12M in a Series C funding round. The round was ...

Los Altos-based Vascular Pathways, a developer of medical devices targeted at peripheral intravenous access, said today that it has raised $14M in a Series B funding round. The round was led by CHL Medical Partners, and also included Ascens...

San Francisco-based healthcare services and IT firm McKesson Corporation said today that it is buying Texas-based US Oncology, an operator of cancer treatment centers. The deal is worth $2.16 billion in cash. McKesson said that the oncology...

Mountain View-based Nellix, a developer of treatments for abdominal aortic aneurysms, has been acquired. According to acquiring firm Endologix, it will pay $15M in stock plus up to $39M in milestone payments for Nellix. As part of the fundi...

Mountain View-based Complete Genomics, a provide of gene sequencing services, has set a pricing range for its IPO. The firm, which is looking to list on the NASDAQ Global Market as GNOM, said it expects its public offering price to be betwe...

Redwood City-based Pearl Therapeutics, a developer of biopharmaceuticals for treating chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases, announced this morning that it has raised $69M in a Series C financin...

Hayward-based Solta Medical, a developer of medical aethetics products, said today that it has acquired CLRS Technology, a provider of personal care solutions. Solta said it will pay approximately $1.1M of debt at closing, plus potential fu...

Santa Clara-based Cell Biosciences announced this morning that it has agreed to acquire Convergent Bioscience Ltd., a Toronto-based developer of protein analysis products, in a deal worth $12M. According to Convergent, the acquisition will ...

Pleasanton-based TriReme Medical, a developer of catheter and stent products, said today that it has raised $17M in a Series D funding round. The round was led by Bio*One Capital, and also included current investors Three Arch Partners and ...

Redwood City-based Pathwork Diagnostics, a developer of molecular diagnostics aimed at the oncology market, said today that it has raised $30M in a Series C financing round. The round was led by Alta Partners, and also included prior invest...

Silicon Valley venture capital firm VantagePoint Venture Partners has backed a New York-based developer of software for managing the patient check-in process for medical offices, Phreesia. Phreesia said VantagePoint led its $20M, Series D r...

San Francisco-based CytomX Therapeutics, a firm developing antibody technology, announced Thursday that it has raised $30M in a Series B funding round. The round was led by Third Rock Ventures, and also included the Roche Venture Fund. As p...

Sunnyvale-based Asthmatx, a developer of a less invastive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma, has been acquired by Boston Scientific, in a deal worth $193.5M in cash plus up to $25...

Boston-based Third Rock Ventures, a venture firm focused on life science companies, said this week that it has closed on Third Rock Fund II, a $426M fund focused on the life science area, and also opened up a San Francisco office. According...

Santa Clara-based Relypsa, a firm developing non-absorbable polymeric drugs for treating renal impairment, hypertension, diabetes and heart failure, said Monday that it has raised $70M in a Series B funding round. The round was led by OrbiM...

Palo Alto-based Anacor Pharmaceuticals, a biopharmaceuticals firm developing small-molecule therapeutics, has filed for an IPO. According to the firm's filing with the SEC, it is looking to raise up to $86.25M in an IPO on the NASDAQ Global...

Dublin, California-based TRIA Beauty, a developer of light-based skincare products based on lasers, said late last week that it raised $15.6M in a new round of growth financing. According to the firm, the round came from Aisling Capital, De...

Menlo Park-based venture capital firm Sofinnova Ventures announced today that it has added Garheng Kong, M.D., Ph.D., as a General Partners. Kong joins the company from Intersouth Partners, where he was also a General Partner. According to ...

Redwood City-based EndoGastric Solutions, a developer of treatments for upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD), announced this morning that it has raised $30M in a Series F financing round. The fun...

South San Francisco-based Solazyme, which is developing biotechnology that uses algae to produce renewable oil and bioproducts, said Thursday that it has added Bunge Limited as a strategic investors in its Series D round. Amount of the inve...

Mountain View-based Complete Genomics, a firm developing and commercializing a DNA sequencing platform, said today that it has raised $39M in a Series E funding round. The round was led by Sands Capital, and also included prior investors Es...

Novato-based BioMarin Pharmaceuticals said last night that it has acquired ZyStor Therapeutics, a biotech firm developing enzyme replacement therapies for treating lysosomal storage disorders. The deal is worth $22M upfront plus up to $93M ...

San Jose-based SI-BONE, a medical device firm developing a minimally invasive surgical device to treat the sacroiliac (SI) joint, said late Tuesday that it has raised $11.0M in a financing round. The round came from new investor Skyline Ven...

Ion Torrent, a developer of DNA sequencing technology, has been acquired by DNA giant Life Technologies, in a deal worth $375M in cash and stock plus up to $350M in earnout. Ion Torrent, which has offices in South San Francisco and headquar...

Solstice Neurosciences, a firm which as its production and manufacturing in San Francisco, but is based out of Malvern, PA, has been acquired. According to Kentucky-based US Worldmeds, it has acquired Solstice Neuroscience for $35M. US Worl...

Menlo Park-based Pacific Biosystems, a developer of tools for DNA, RNA, and protein analysis, has filed for an IPO. According to an S-1 filed by the firm this morning, it is looking to raise up to $200M on the NASDAQ Global Market as PACB. ...

Menlo Park-based Neodyne Biosciences, a stealth mode biotechnology firm developing technology related to plastic surgery and wound care, has raised $5.8M in funding, according to a recent regulatory filing. No details on the firm, nor its f...

Palo Alto-based Tenaxis Medical, a developer of surgical sealants, has raised $9.56M in a new round of funding, according to a regulatory filing by the firm this week. The funding appears to be part of an ongoing, $16.6M funding round for t...

Mountain View-based Complete Genomics, a provider of human genome sequencing services, said Friday that it has filed for an $86.25M IPO. The firm said it is looking to trade as GNOM on the Nasdaq. The IPO is being underwritten by UBS Invest...

Pleasanton-based Thoratec, a developer of ventricular assistant devices for patients with heart failure, said today that it has terminated its agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation....

San Mateo-based Epocrates, a provider of drug reference information via mobile phones, has re-filed for an IPO. The firm said it is looking to raise up to $75M on the NASDAQ Global Market under the symbol "EPOC". The IPO is being underwritt...

Menlo Park-based Pacific Biosciences, a firm developing technology for the real-time detection of biological events, said Wednesday that it has completed a $109M, Series F financing. The round includes a previously announced $50m investment...

Sunnyvale-based BARRX Medical, a developer of treatments for Barrett's esophagas, a precancerous condition of the esophagus, said today that it has raised $15M in a Series D funding round. The round was led by Highland Capital Partners, and...

Santa Rosa-based Trivascular, a developer of medical stent graft systems for treating aortic aneurysms, said this week that it has raised $60M in a Series C funding round. The round was led by Pinnacle Ventures, and also included New Enterp...

Belmont-based Ventus Medical, a medical device firm developing a treatment for sleep apnea, said this week that it has raised $40M in a Series D funding round. Source of the new funding was not disclosed. Ventus also said it has named Peter...

South San Francisco-based iPierian, a firm developing stem cell-based biopharmaceuticals for the drug discovery market, said Thursday that it has raised $22M in a Series B equity funding. The round was led by Google Ventures, and also inclu...

San Jose-based DFine, which develops minimally invasive treatments for stabilizing vertebral fractures, said this week that it has raised $36.2M in a new round of funding. The round was led by Split Rock Partners, and also included Orbimed,...

South San Francisco-based Calithera Biosciences said today that it has raised $40M in a Series A financing round. The round was led by Morgenthaler Ventures, and also included U.S. Venture Partners, Advanced Technology Ventures, Delphi Vent...

Redwood City-based Incline Therapeutics, a specialty pharmaceuticals firm developing a transdermal, patient-controlled analgesia system for post-surgey patients, has scored $43M in a Series A venture financing. The firm said Monday that the...

Menlo Park-based Pacific Biosciences, a developer of DNA sequencing technology, has received $50M in an investment from Gen-Probe, the firms announced Thursday. According to the firm, the investment comes as part of a deal to co-develop new...

San Francisco-based Practice Fusion, a developer of electronic medical records software, said today that it has added angel investor and former Intuit exec Mark Goines to is baord of directors. Goines was most recently Senior Vice President...

South San Francisco-based Veracyte, a developer of molecular cytology diagnostic products, has raised $28M in a Series B round. The round was led by Domain Associates, and also included Kleiner Perkins Caufield & Byers, TPG Biotech, and Ver...

San Francisco-based Castlight Health, which delivers a web-based service to provide employees with information about health care benefits and costs, has raised $60M in a Series C funding. The firm said the round came from Morgan Stanley Inv...

Fremont-based Quark Pharmaceuticals, a developer of RNAi-based therapeutic products, announced Thursday that it has raised $10M in a funding round. The round came from Japanese firm SBI Holdings Group. As part of the funding, Quark said it ...

Pleasanton-based Zeltiq, a firm developing medical devices for fat reduction, announced yesterday that it has raised $25M in a Series D funding round. The round was led by Aisling Capital, and also included its prior investors Advanced Tech...

Mountain View-based Alexza Pharmaceuticals, a publicly held firm focused on treatment of central nervous system conditions, said today it has received a committed equity financing facility worth $25M. The funding comes from Azimuth Opporuni...

San Ramon-based Breathe Technologies, a developer of medical devices for trating chronic obstructive pulmonary disease and sleep apnea, said Tuesday that it has raised $23M in a Series C funding round. The round was led by DAG Ventures, and...

San Francisco-based iRhythm Technologies, which develops a cardiac rhythm monitor, has scored $10M in a funding from St. Jude Medical, Mohr Davidow Ventures, and Synergy Life Science Partners, St. Jude and iRhythm announced Thursday. Accord...

Mountain View-based Intuit said Monday evening that it has acquired Medfusion, a North Carolina-based firm providing online software for healthcare providers. The deal was worth $91M in cash. According to Intuit, the acquisition will accele...

San Mateo-based NeurogesX, a biopharmaceuticals firm focused on pain management, said today that it has entered into a $40M royalty financing agreement, from Cowen Healthcare Royalty Partners, L.P. According to the firm, the debt funding wi...

Palo Alto-based Viveve, a firm developing non-surgical, vaginal tissue restoration technology for women, has received $4.0M in a funding round, according to a regulatory filing from the firm this week. The firm is backed by 5AM Ventures and...

San Francisco-based Healthline Networks, which operates consumer related health information web sites, announced Tuesday that it has raised $14M in a third roudn of funding. The round was led by Investor Growth Capital. Peacock Equity Fund ...

Redwood City-based Codexis, a developer of biocatalysts for the pharmaceutical and biofuels industries, said today that it has priced its IPO at $13.00 a share. The firm is selling 6,000,000 shares of its common stock on the NASDAQ Global M...

Redwood Shores-based Oracle said Friday that it has acquired publicly held Phase Forward, a developer of software-as-a-service applications for collecting clinical trial data. Oracle said it would pay approximately $685M, or $17.00 per shar...

Menlo Park-based Amplyx Pharmaceuticals announced Thursday that the firm has raised $1.5M in a Series A funding round. According to the firm, the round came from Golden Seeds, a nationwide angel group investing in women-led companies, with ...

Mountain View-based IRIDEX Corporation, a developer of laser-based medical devices, said today that it has acquired the ophthalmology products of RetinaLabs, based in Atlanta. According to IRIDIX, the acquisition covers substantially all of...

San Francisco-based Achaogen, a biopharmaceuticals firm focused on developing antibiotics, announced today that it has raised $56M in a Series C round. The round was led by Frazier Healthcare Ventures, and included Alta Partners, 5 AM Ventu...

South San Francisco-based Altheos announced today that it has raised $20M in a Series A funding. The firm, which is licensing a set of compounds from Japanese firm Asahi Kasei Pharma for the topical treatment of glaucoma, said the funding w...

Sunnyvale-based U-Systems, a developer of automated breast ultrasound systems, announced Thursday afternoon that it has raised $10M in a funding round. The round was led by iD SoftCapital Group, and also included Sycamore Ventures, Lumira C...

Menlo Park-based Allocade, which develops healthcare software, said Wednesday that the firm has raised $5M in a venture funding round. The round was led by VantagePoint Venture Partners. Allocde said the funding will use to scale the firm's...

South San Francisco-based Poinard Pharmaceuticals, a publicly held biopharmaceuticals firm, said today that it has raised $6.3M in a share sale to Commerce Court Small Cap Value Fund, Ltd. The firm said the funding will go to fund continued...

South San Francisco-based NGM Biopharmaceuticals said today that it has closed on the first tranche of a $51, Series B round of funding. The round came from The Column Group, Tichenor Ventures, LLC, Prospect Venture Partners, Rho Ventures, ...

Hercules, California-based Eureka Genomics, a firm focused on using advanced bioinformatics analysis of genetic sequencing data to develop drugs, said Wednesday that it has raised $3.7M in a round of funding from private individuals and ang...

Redwood City-based Facet Biotech, a developer of treatments for multiple sclerosis, has been acquired by Abbott, in a deal worth $450M. According to Abbott, it will pay $27 per share in cash for Facet, for a purchase price of approximately ...

San Francisco-based Vaxart, a developer of oral vaccines, said today that it has raised $12.5M in a Series B funding round. The round was led by Care Capital. As part of the funding, Richard Markham and Jan Leschly of Care Capital have join...

Davis-based Gold Standard Diagnostics, a firm providing tools for the medical research and laboratory diagnostics industry, said Tuesday that it has raised a Series A round of funding. Amount of the funding was not disclosed. The firm said ...

San Mateo-based TwoF, a developer of proprietary technology for production of DNA microarrays, has raised $2.1M in an ongoing, $3.0M funding round, according to a regulatory filing by the firm this week. No details on the funding have been ...

San Francisco-based Mb>DNA Direct, a provider of information about genetics testing, has been acquired by New Jersey firm Medco Health Solutions. Financial terms of the buy were not disclosed. DNA Direct was venture backed by Firefly Invest...

Pleasanton-based Juvaris Therapeutics, which is developing adjuvanted vaccines for improving the effectiveness of influenza vaccination, said today that it has had a second close of its Series B funding worth up to $25M. The new funding cam...

San Francisco-based Vaxart, a developer of oral vaccines, has raised nearly $3.5M out of an ongoing $12.5M funding round, the firm disclosed in a regulatory filing Thursday. Source of the new funding was not disclosed. The firm's pipeline ...

Menlo Park medical device company incubator The Foundry reported Wednesday that it has received $3M in a Series A financing for its twelfth new company. Name of the new company--refereed to as "Foundry Newco XII"--was not disclosed. Accordi...

Menlo Park medical device company incubator The Foundry reported Wednesday that it has received $3M in a Series A financing for its twelfth new company. Name of the new company--refereed to as "Foundry Newco XII"--was not disclosed. Accordi...

San Jose-based Dfine, a developer of medical devices for treating spine fractures, has raised $2.83M out of an ongoing, $3.0M funding raising effort, according to a regulatory filing by the firm Monday. No details on the funding have been a...

Sunnyvale-based Neuralieve, a developer of a medical device for relieving migraine pain, has raised $3.89M out of an ongoing $7.5M fundraise, according to a regulatory filing by the firm. Source of the new funding was not disclosed, however...

Newark-based Revance Therapeutics announced today that it has raised $25M in the first close of a $35M, Series D financing round, confirming information first disclosed in a regulatory filing last week. According to Revance, the new funding...

Mountain View-based ReVance Therapeutics has raised $25.62M in a Series D funding, according to a regulatory filing by the firm last week. Source of the new funding was not disclosed. ReVance has previously received funding from Bio*One Cap...

Palo Alto-based Afferent Pharmaceuticals, a developer of chronic pain treatments, has raised $23M in a Series A financing round, the firm said today. The round was led by Third Rock Ventures and Pappas Ventures, and also included Domain Ass...

Soquel-based Monterey Devices, a stealth mode developer of a drug delivery system, has raised $2.5M out of a $7.0M funding round, according to a regulatory filing by the firm this week. The firm lists a representative of MOntage Capital, a ...

San Francisco-based private equity firm Francisco Partners reported Tuesday that it is acquiring QuadraMed Corporation, a provider of healthcare information technologies and services. The deal is worth approximately $126M in cash. Francisco...

Menlo Park-based 5AM Venture Management said Monday that it has raised $200M in 5AM Ventures III, L.P., the firm's venture capital fund focused on early-stage life sciences companies. The firm said the funding came from both current and new...

Redwood City-based EndoGastric Solutions, a developer of medical devices for treating gastroesophageal reflux disease (GERD), has raised $21.5M in a Series E funding round. The funding came from current investors. The company said that the ...

Santa Rosa-based TriVascular, a developer of stent graft treatments for abdominal and thoracic aortic disease, said this week that it has raised $30M in a Series B funding round. The firm said the funding came from New Enterprise Associates...

Pleasanton-based Microchip Biotechnologies, a developer of scientific equipment for sample processing in the life sciences and applied sciences area, announced today that it has raised $18.1M in a Series B financing. The round was led by Do...

Sunnyvale-based Labcyte, a developer of liquid handling equipment and lab instrumentation, has raised $5.5M in a venture debt funding. According to funding firm Hercules Technology Growth Capital, it provided the $5.5M as a credit facility ...

Menlo Park-based Spinal Modulation, a developer of medical devices for treating back pain, said Thursday that it has raised $27.4M in a Series C funding round. The round came from Johnson & Johnson Development Corporation, DeNovo Ventures, ...

Mill Valley-based Mytrus, a stealth mode firm which says it is "bringing clinical trials directly to participants," has raised $1.0M in a funding round, according to regulatory filings. No details on the funding have been released by the co...

South San Francisco-based Nodality has raised $3.5M out of an ongoing, $10M fundraising effort, according to a regulatory filing by the firm this week. The firm is developing personal diagnostics technology, specifically focused on detectin...

Palo Alto-based Aviir, a firm developing diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease based on research out of Stanford, has raised $1.0M in a combination of equity and debt, along with warrants. The ...

Emeryville-based Onyx Pharmaceuticals said today that it is in a definitive agreement to acquire South San Francisco-based Proteolix, a biopharmaceuticals firm focused on treating hematological malignancies and solid tumors. Onyx said it wi...

San Mateo-based Caring.com, which operates an online site about healthcare options and senior care for aging parents, said Wednesday that it has acquired Gilbert Guide, an online senior housing guide and homecare directory, as well as a pro...

Santa Rosa-based Direct Flow Medical, a developer of aortic tissue value prothesis, has scored $40M in a venture funding round, according to a regulatory filing by the firm. No details on the funding have been announced by the company. The ...

Mountain View-based Google Ventures, the venture capital arm of Google, has led an investment in Adimab, a New Hampshire firm focused on human antibody discovery. According to Adimab, Google was joined by Polaris Ventures, SV Life Sciences,...

San Francisco-based Jennerex, a developer of oncolytic virus therapeutics, said late last week that it has closed its second tranche of Series C funding. The firm said the round close dout at $5,611,475, above the firm's target of $5M. The ...

Burlingame-based Juvaris BioTherapeutics announced Thursday that the firm had a first close on a $25M, Series B financing round. The new funding was led by SV Life Sciences and Kleiner Perkins Caufield & Byers. The firm did not say what the...

Cupertino-based NextBio, which is developing an online platform for sharing information between life science researchers, said today that it has closed an $8M, Series C venture funding round. The round was led by Newbury Ventures, and also ...

San Carlos-based Alvine Pharmaceuticals, a biopharmaceuticals firm developing treatments for celiac disease, announced Tuesday that it has raised $21.5M in a Series A extension funding round. The funding was led by Panorama Capital, and als...

Menlo Park-based Evalve, a developer of minimally invasive cardiac valve repair technology, has been acquired by Abbott. Abbott said it would pay $320M in cash plus milestone payments, worth up to a total of $410M, for Evalve. Evalve was fo...

Foster City-based VitaPath Genetics, which is developing molecular diagnostics for detecting Spina Bifida, said today that it has raised $6M in a Series A funding round. The round was led by MDV-Mohr Davidow Ventures, and also included fun...

Santa Clara-based Cell Biosciences said late Tuesday that it has acquired Alpha Innotech Corp in a deal worth approximately $17.9M in cash. San Leandro-based Alpha Innotech develops digital imaging systems for genomic and proteomic research...

Biogen Idec said Friday that it has launched an effort to acquire Redwood City-based Facet Biotech, in a deal worth $14.50 per share in cash for Facet. According to Biogen Idec, the offer is approximately 64% over the September 3rd closing ...

Hayward-based Advanced Cell Diagnostics (ACD), a developer of cell- and tissue-based diagnostic tests for personalized medicine, announced late Wednesday that the firm has completed a second close on a $5.4M, Series A funding. The financing...

South San Francisco-based Fluidigm, a developer of integrated fluidic circuits for the life sciences industry, has raised $10.67M in a funding round, according to a regulatory filing by the firm today. The round is part of a ongoing, $14M f...

Emeryville-based Athena Feminine Technologies, which is developing treatments for female incontinence, announced today that the firm has raised $2M in a Series A investment round. The round came from vSpring Capital. The firm said that the ...

Mountain View-based Complete Genomics said today that it has raised $45M in a Series D financing round. The round was led by Essex Woodlands Health Ventures and OrbiMed Advisors, with existing investors Enterprise Partners Venture Capital, ...

Santa Clara-based OptiMedica, a firm developing medical laser technology for treating retinal disease, has raised $25M as part of a Series D funding round. The funding was disclosed in a regulatory filing. According to the filing, the firm ...

San Francisco-based Jennerex, a biopharmaceuticals firm developing oncolytic virus therapeutics targeted at treatment of liver, colon, and lung cancer, said this week that it has raised $5.1M in a funding round as part of a private placemen...

San Francisco-based Practice Fusion, a developer of web-based applications for patient health record tracking, disclosed this week that the firm has raised a round of funding from Salesforce.com. Amount of the investment was not disclosed. ...

Brisbane-based XDx, a firm working on molecular diagnostics, reported Wednesday that it has raised $14.4M in a Series G financing round. The round was led by Bristol-Myers Squibb, along with prior investors Burrill Venture Capital; Duff, Ac...

Signostics, which also has operations in Australia and an office in Palo Alto, said late Tuesday that it has raised $4M for the firm's personal ultrasound devices. The firm said the funding round came from Brandon Capital Partners, Playford...

Newark-based Novasys Medical, which develops a treatment for female stress urinary incontinence, reported today that it has raised $18.95M in a second tranche of its Series D funding round. The funding came from Versant Ventures, ThreeArch ...

South San Francisco-based Limerick BioPharma reported today that it has raised $15M in a Series C funding round. The round was led by OVP Venture Partners, and also included prior investors ARCH Venture Partners, Sevin Rosen Funds and Altit...

San Francisco-based Presidio Pharmaceuticals said Thursday afternoon that it has raised another $27M for the firm. The company, which is focused on developing treatments for viral infections, including HIV-1 and HCV, said the round included...

Fremont-based Zosano Pharma, which develops transdermal drug delivery technology, said today that it has raised $30M in a new roun dof financing. Zosano said that Nomura Phase4 Ventures led the round, with all of its existing investors part...

South San Francisco-bsaed iZumi Bio and Boston-based Pierian, two biotech firms focused on stem cell based therapeutics, said today that they have merged to form a new company, iPierian, and also raised funding worth $11.5M. The two said th...

Redwood City-based Relievant Medsystems reports today that it has raised $20M in a private equity financing round. According to Relievant, the round was led by Morgenthaler Ventures, and also included Canaan Partners, ONSET Ventures, and Em...

South San Francisco-based Hyperion Therapeutics, which is developing pharmaceuticals for the gastroenterology and hepatology areas, announced today that it has raised $60M in a Series C financing round. The round was led by Bay City Capital...

Menlo Park-based 5AM Ventures, a venture investor in the life sciences industry, has now hit $159.25M in its fundraising for 5AM Ventures III, according to a regulatory filing from the firm today. Details on limited partners in the fund hav...

San Francisco- and Paris-based SpineGuard, which is developing medical devices for back surgery, said this morning that it has raised $4M in a funding round from Delta Partners. According to the firm, the investment brings its Series A fund...

Mountain View-based Google disclosed Thursday in a regulatory filing that the firm has invested $2.6M in 23andMe, the genetic analysis firm headed by Sergey Brin's wife, Anne Wojcicki. According to Google, the investment came in 23andMe's S...

Redwood Shores-based Oracle said late Wednesday that the firm has acquired the intellectual property assets of Conformia Software. Financial terms of the acquisition were not disclosed. Conformia is a developer of product and process lifecy...

South San Francisco-based Alios BioPharma disclosed this morning that the firm has raised $32M in a Series A, preferred stock financing for the firm's biotechnology efforts. According to the firm, the round came from new investor SR One, th...

Menlo Park-based Apieron revealed Monday that the firm has received commitments from Alliance Technology Ventures, Canaan Partners, Draper Fisher Jurvetson and Onset Ventures--all existing investors in the firm--for a Series D round. Fundin...

Redwood City-based Versartis, a new joint venture between Amunix Inc. and Index Ventures, said today that it has raised $11M in a Series A financing round. The round came from index Ventures. According to the company, it was created to expl...

San Ramon-based Endoscopic Technologies, a developer of cardiac surgery devices, announced today that the firm has raised $8M in a n equity financing raise. According to the firm, the funding was led by NBGI Ventures, and also included Sai...

Clovis Oncology, a new biotech startup focused on commercializing anti-cancer agents, disclosed today that it has raised $145M for the firm. The firm, which has offices in San Francisco but is based in Boulder, Colorado, said the funding ca...

Menlo Park-based Autonomic Technologies, a stealth mode developer of implantable medical devices for treating severe headaches, has raised $20M in a Series B funding, according to lead investor Interwest Partners. Details on the funding hav...

Menlo Park-based venture capital firm Interwest Partners said today that it has made the first four investments from its tenth fund, InterWest X. According to InterWest, it led a $15M Series B financing for Exalt Communications, and co-led ...

Mountain View-based 23andMe, the personal genomics startup headed by Anne Wojcicki, has raised $11M of a $24.26M funding round, silicontap.com has learned. According to a regulatory filing, 23andMe raised the equity on April 16th. Details o...

Mountain View-based Google is looking to apply its search footprint to help track the interest in the swine flu outbreak, through an expansion of its Google Flu Trends service. According to Google, it is now breaking out searches for flu-re...

French biotech firm Sanofi-aventis said Wednesday that the firm has signed an agreement to acquire Brisbane, California-based BiPar Sciences. BiPar is a developer of cancer treatments. According to the firms, the deal is worth up to $500M, ...

Palo Alto-based Cell Biosciences, a developer of instrumentation systems for the life science industry, announced Thursday that the firm has raised $10M in a Series C round. The round was led by the Wellcome Trust, and also included prior i...

Berkeley-based Aerovance, a biopharmaceuticals firm focused on treatments for respiratory and inflammatory diseases, said Tuesday that it has raised $38M in an equity financing round. According to the firm, the round was led by ProQuest Inv...

Menlo Park-based Neuraltus Pharmaceuticals, which is developing small molecule drugs for treating neurodegenerative diseases, said this morning that it has raised $17M in a Series A financing round. According to the firm, the funding came f...

Redwood City-based Oracle announced this morning that it has agreed to acquire Relsys International, a developer of drug safety and risk management products for the health sciences industry. Financial details of the buy were not disclosed. ...

San Bruno-based Numerate, a biotech firm developing small molecule therapeutics, said Wednesday that it has raised $5.5M in a Series B funding. The company said that Foundation Capital led the round, which also included Lanza techVentures. ...

Mountain View-based 23andMe, the DNA testing startup co-founded by Anne Wojcicki and backed by Google, said Thursday that the firm is launching an effort to help advance research into Parkinson's disease. The firm said that it is in a colla...

Irving L. Weissman, M.D., an expert on stem cells, and Director of the Stanford Institute for Cancer/Stem Cell Biology and Medicine, has linked with a venture capital firm based in Seattle. According to OVP Venture Partners, Weissman joins ...

Pleasanton-based Arcxis Biotechnologies, which develops biomedical devices for extracting, isolating, and purifying RNA and DNA, said Thursday afternoon that the firm has scored an investment from In-Q-Tel, the venture capital arm of the CI...

Palo Alto-based Eiger BioPharmaceuticals Inc. announced Tuesday that its first round of venture financing has yielded $7.1 million. The firm credited InterWest Partners and Vivo Ventures with leading the Series A effort. Both investors hel...

South San Francisco-based Alios BioPharma, which is developing small-molecule and protein-based therapeutics, said Thursday that it has raise $8.4M in a Series A funding round. The firm said the funding is the first tranche in a commitment ...

San Francisco-based Linkage Biosciences disclosed Wednesday that the firm has raised $2M in a Series A funding round. The round was led by Greenhouse Capital Partners and James R. Fisher, who is a managing member of Fisher Capital Corp. II ...

Hayward-based Guava Technologies, which develops bench top cell analysis systems for the life sciences industry, has been acquired by Massachusetts-based Millipore, Millipore said today. According to Millipore, it will pay $22.6M for Guava....

Pleasanton-based Arcxis Biotechnologies, which is developing biomedical devices, said Friday that the firm has completed the first close of a Series B funding round. Amount of the funding was not disclosed. Arcxis said that Claremont Creek ...

Menlo Park-based Cantimer, which is developing senors for measuring human hydration from saliva, said Thursday that it has scored $1M in an equity investment. The funding came from Advanced Instruments Inc., and was part of a deal to collab...

Redwood Shores-based Omnitura, a biopharmaceutcals firm marketing multivalent drugs for the treatment of cancer, said Thursday that the firm has raised $24M in a private placement. The firm did not disclose investors, but said that the fina...

Alameda-based Avigen said Wednesday that the firm has hired two investment banks to evaluate offers for the firm and its assets. According to the firm, RBC Capital Markets and Pacific Growth Equities LLC will oversee review of merger and ac...

Alameda-based Singulex said this week that it has raised $19M in a venture financing round, led by JAFCO Co., Ltd. The firm said that the round also included prior investors Orbimed Advisors and Fisk Ventures. Hironori Hozoji of JAFCO Life ...

Brisbane, California-based BiPar Sciences, a biopharmaceuticals firm focused on treatments for breast cancer, said Tuesday morning that it has raised $20M in a combination of equity and venture debt. The firm said the funding came from its ...

Menlo Park-based Alter-G, which develops medical devices for the rehabilitation market, said Tuesday that it has raised $8M in a Series B funding round. The funding came from Versant Ventures. The firm said that Ross Jaffe of Versant Ventur...

Menlo Park-based Acclarent, which develops medical devices for treating ear, nose, and throat conditions, said today that it has raised $26M in a financing round. The round came from Johnson & Johnson Development Corporation, along with exi...

Redwood City-based Gene Security Network, which develops molecular diagnostics technology to enhance genetic testing, said Wednesday that it has closed on a $6M Series B funding round. The new funding came from current investors Claremont C...

Palo Alto-based Anacor Pharmaceuticals, a developer of small molecule drugs focused on treating fungal, bacterial, and inflammatory diseases, said Tuesday that it has scored another $50M in a preferred stock financing. The funding came from...

South San Francisco- and Cambridge-based venture capital firm Clarus Ventures, LLC, said this morning that it has named two new partners. The firm said that it has promoted Emmett Cunningham to Partner and Scott Requadt as Transactional Par...

South San Francisco-based KaloBios Pharmaceuticals disclosed Monday that the biotech firm has raised $12M in a second close of its Series D venture funding. According to the firm, the additional capital came from Baxter International Inc. T...

San Francisco- and Boston-based venture firm SV Life Sciences said Thursday that it has named a new Venture Partner at the firm. The venture capital firm, which makes investments in biotechnology & pharmaceuticals, medical devices & instrum...

San Francisco-based DecisionView, a supplier of software used for managing clinical trials, announced Tuesday that it has closed a Series D investment. The funding round came from Granite Ventures, Adobe Ventures, and Aeris Capital. Amount ...

Mountain View-based Broncus Technologies, which is developing medical devices for treating emphysema, said Thursday that it has raised $38M in a Series G Funding. The round was led by Ares Life Sciences AG, which invested $25M in the firm. ...

Hayward-based Arete Therapeutics, which is a biotechnology firm focused on soluble epoxide hydrolase (s-EH) inhibitors, has added $16.7M in a Series A tranche financing. According to Arete, the tranche was led by Frazier Healthcare Ventures...

Fremont-based Panomics, a developer of genetic assay products, has been acquired by Santa Clara-based Affymetrix, Affymetrix said Tuesday. Affymetrix said it will pay approximately $73M in cash for Panomics. Panomics develops scientific ins...

San Jose-based DFine, a developer of medical devices for treating vertebral compression fractures, said Tuesday that it has raised $30M in a Series D investment. The new round was led by BBT Fund LP and Highland Capital Management and also ...

Cupertino-based BioImagene, a developer of digital pathology products, said Thursday that it has added Siemens Venture Capital as a new investor in the firm. BioImagene said that the funding follows the recently close of a $26M Series D fin...

Burlingame-based APT Pharmaceuticals, which is developing treatments for serious lung diseases, said Tuesday that it has raised $32.3M in a Series B funding. The round was led by Three Arch Partners, and also included new investors InterWes...

Amplyx Pharmaceuticals, a drug development firm developing small molecule drugs, has raised a Series A funding round, worth roughly $700K. The funding came from the Tech Coast Angels and life Science Angels. According to the Tech Coast Ange...